Aldo Ammendola PhD, MBA, RAC
Nürnberg Area, Germany
Head Division Research & Development at Bionorica SE
Pharmaceuticals
Education
Open University Business School (UK) 2005 — 2008
MBA, Business Administration, Strategy, Finance, Creativity, Innovation, Change
Technical University of Munich 1996 — 1999
PhD, Molecular and Microbiology
Experience
Bionorica SE 2014 - Present
4SC AG 2010 - 2014
4SC AG 2008 - 2010
QuoNova Europe GmbH / LLC 2007 - 2009
Capgemini Strategy Consulting 2005 - 2007
4SC AG 2003 - 2005
4SC AG 2001 - 2003
Technical University of Munich 1999 - 2000
Skills
Pricing, Commercialization, R&D, Clinical Trials, Financial Modeling, Due Diligence, Venture Capital, Pharmacology, Biotechnology, Inflammatory Bowel..., Strategy, Forecasting, Clinical Research, GCP, Pharmaceutics, Management Consulting, Business Strategy, IND, CRO, Immunology, Valuation, Autoimmune Diseases, Toxicology, Biopharmaceuticals, Strategic Planning, Corporate Development, Oncology, Pharmaceutical Industry, Medical Devices, Licensing, Reimbursement, Regulatory Affairs, Vaccines, Health Economics, Competitive Intelligence, GLP, GMP, Lifesciences, Therapeutic Areas, Drug Development, FDA, Out-licensing, Business Development, Market Access, Clinical Development, Drug Discovery, Rheumatoid Arthritis